+ADw-html xmlns:v+AD0AIg-urn:schemas-microsoft-com:vml+ACI- xmlns:o+AD0AIg-urn:schemas-microsoft-com:office:office+ACI- xmlns:w+AD0AIg-urn:schemas-microsoft-com:office:word+ACI- xmlns:st1+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- xmlns+AD0AIg-http://www.w3.org/TR/REC-html40+ACIAPg- +ADw-head+AD4- +ADw-meta http-equiv+AD0-Content-Type content+AD0AIg-text/html+ADs- charset+AD0-utf-7+ACIAPg- +ADw-meta name+AD0-ProgId content+AD0-Word.Document+AD4- +ADw-meta name+AD0-Generator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-meta name+AD0-Originator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-link rel+AD0-File-List href+AD0AIg-als24316+AF8-files/filelist.xml+ACIAPg- +ADw-link rel+AD0-Edit-Time-Data href+AD0AIg-als24316+AF8-files/editdata.mso+ACIAPg- +ADwAIQ---+AFs-if +ACE-mso+AF0APg- +ADw-style+AD4- v+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- o+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- w+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- .shape +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-title+AD4-Anti-CIDE 3 antibodies from RDI Division of Fitzgerald Industries Intl+ADw-/title+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-country-region+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-PostalCode+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-State+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-City+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-Street+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-address+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-place+ACI-/+AD4- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:DocumentProperties+AD4- +ADw-o:Author+AD4-Martha Rozynski+ADw-/o:Author+AD4- +ADw-o:LastAuthor+AD4-Martha Rozynski+ADw-/o:LastAuthor+AD4- +ADw-o:Revision+AD4-2+ADw-/o:Revision+AD4- +ADw-o:TotalTime+AD4-0+ADw-/o:TotalTime+AD4- +ADw-o:Created+AD4-2008-05-16T21:11:00Z+ADw-/o:Created+AD4- +ADw-o:LastSaved+AD4-2008-05-16T21:11:00Z+ADw-/o:LastSaved+AD4- +ADw-o:Pages+AD4-1+ADw-/o:Pages+AD4- +ADw-o:Words+AD4-384+ADw-/o:Words+AD4- +ADw-o:Characters+AD4-2190+ADw-/o:Characters+AD4- +ADw-o:Company+AD4-Trinity Biotech USA+ADw-/o:Company+AD4- +ADw-o:Lines+AD4-18+ADw-/o:Lines+AD4- +ADw-o:Paragraphs+AD4-5+ADw-/o:Paragraphs+AD4- +ADw-o:CharactersWithSpaces+AD4-2569+ADw-/o:CharactersWithSpaces+AD4- +ADw-o:Version+AD4-11.9999+ADw-/o:Version+AD4- +ADw-/o:DocumentProperties+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:WordDocument+AD4- +ADw-w:GrammarState+AD4-Clean+ADw-/w:GrammarState+AD4- +ADw-w:ValidateAgainstSchemas/+AD4- +ADw-w:SaveIfXMLInvalid+AD4-false+ADw-/w:SaveIfXMLInvalid+AD4- +ADw-w:IgnoreMixedContent+AD4-false+ADw-/w:IgnoreMixedContent+AD4- +ADw-w:AlwaysShowPlaceholderText+AD4-false+ADw-/w:AlwaysShowPlaceholderText+AD4- +ADw-w:BrowserLevel+AD4-MicrosoftInternetExplorer4+ADw-/w:BrowserLevel+AD4- +ADw-/w:WordDocument+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:LatentStyles DefLockedState+AD0AIg-false+ACI- LatentStyleCount+AD0AIg-156+ACIAPg- +ADw-/w:LatentStyles+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if +ACE-mso+AF0APgA8-object classid+AD0AIg-clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D+ACI- id+AD0-ieooui+AD4APA-/object+AD4- +ADw-style+AD4- st1+AFw-:+ACoAew-behavior:url(+ACM-ieooui) +AH0- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-style+AD4- +ADwAIQ--- /+ACo- Style Definitions +ACo-/ p.MsoNormal, li.MsoNormal, div.MsoNormal +AHs-mso-style-parent:+ACIAIgA7- margin:0in+ADs- margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- p +AHs-font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- span.GramE +AHs-mso-style-name:+ACIAIgA7- mso-gram-e:yes+ADsAfQ- +AEA-page Section1 +AHs-size:8.5in 11.0in+ADs- margin:1.0in 1.25in 1.0in 1.25in+ADs- mso-header-margin:.5in+ADs- mso-footer-margin:.5in+ADs- mso-paper-source:0+ADsAfQ- div.Section1 +AHs-page:Section1+ADsAfQ- --+AD4- +ADw-/style+AD4- +ADwAIQ---+AFs-if gte mso 10+AF0APg- +ADw-style+AD4- /+ACo- Style Definitions +ACo-/ table.MsoNormalTable +AHs-mso-style-name:+ACI-Table Normal+ACIAOw- mso-tstyle-rowband-size:0+ADs- mso-tstyle-colband-size:0+ADs- mso-style-noshow:yes+ADs- mso-style-parent:+ACIAIgA7- mso-padding-alt:0in 5.4pt 0in 5.4pt+ADs- mso-para-margin:0in+ADs- mso-para-margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:10.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-ansi-language:+ACM-0400+ADs- mso-fareast-language:+ACM-0400+ADs- mso-bidi-language:+ACM-0400+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-meta name+AD0-description content+AD0AIg-Anti-CIDE 3 antibodies from RDI Divison of Fitzgerald Industries Intl.+ACIAPg- +ADw-meta name+AD0-keywords content+AD0AIg-rdi-als24316, cide 3, cide3+ACIAPg- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:shapedefaults v:ext+AD0AIg-edit+ACI- spidmax+AD0AIg-2050+ACI-/+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:shapelayout v:ext+AD0AIg-edit+ACIAPg- +ADw-o:idmap v:ext+AD0AIg-edit+ACI- data+AD0AIg-1+ACI-/+AD4- +ADw-/o:shapelayout+AD4APA-/xml+AD4APAAhAFs-endif+AF0---+AD4- +ADw-/head+AD4- +ADw-body lang+AD0-EN-US link+AD0-blue vlink+AD0-blue style+AD0-'tab-interval:.5in'+AD4- +ADw-div class+AD0-Section1+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-rev+ADw-/span+AD4-: +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- 5/16/2008+ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/index.htm+ACIAPg-HOME+ADw-/a+AD4- +ACY-nbsp+ADs- (index page) +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/absort.htm+ACIAPg-Return +ADw-/a+AD4AJg-nbsp+ADs- (alphabetical antibody page) +ADw-/p+AD4- +ADw-p align+AD0-center style+AD0-'text-align:center'+AD4APA-br+AD4- +ADw-b+AD4AJg-nbsp+ADs- ANTIBODIES+ADw-/b+AD4- +ACY-nbsp+ADs- +ADw-/p+AD4- +ADw-p align+AD0-center style+AD0-'text-align:center'+AD4-(+ADw-span class+AD0-GramE+AD4-anti-Human+ADw-/span+AD4- and others as indicated) +ADw-/p+AD4- +ADw-p+AD4-RDI Division of Fitzgerald Industries +ADw-span class+AD0-GramE+AD4-Intl +ACY-nbsp+ADs-offers+ADw-/span+AD4- a wide line of +ACY-nbsp+ADs-antibodies. Since no one antibody works best for all applications (neutralization, blotting, ELISA, etc), we offer many different types of antibodies to help solve this problem. Please inquire for other applications or types of antibodies not listed below. +ADw-/p+AD4- +ADw-div class+AD0-MsoNormal align+AD0-center style+AD0-'text-align:center'+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- align+AD0-center+AD4- +ADw-/div+AD4- +ADw-p class+AD0-MsoNormal+AD4APA-b+AD4-Anti-human CIDE-3 Polyclonal Antibody+ADw-/b+AD4- +ADw-/p+AD4- +ADw-p+AD4-Catalog Number: RDI-ALS24316 +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADsAJA-346.50/100ug +ADw-/p+AD4- +ADw-p+AD4AJg-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- RDI-ALS24316X +ACY-nbsp+ADs- +ACQ-1875.00/1mg +ADw-/p+AD4- +ADw-p+AD4APA-st1:place w:st+AD0AIg-on+ACIAPg-Lot+ADw-/st1:place+AD4- Number: +ADw-/p+AD4- +ADw-p+AD4-Quantity: 100ug in 100ul (1 mg/ml) in PBS containing 0.02+ACU- sodium azide. +ADw-/p+AD4- +ADw-p+AD4-Description: DNA fragmentation is one of the critical steps in apoptosis, which is induced by DNA fragmentation factor (DFF). DFF is composed of two subunits, a 40 kDa caspase-activated nuclease (DFF40) and a 45 kDa inhibitor (DFF45). Recently a novel family of cell-death-inducing DFF45-like effectors (CIDEs) has been identified. Human CIDE-3 is a novel member of CIDEs. There are 2 transcripts, CIDE-3 and CIDE-3alpha, were present in HepG2 and A375 cells. Consistent with its chromosome localization at 3p25, a region associated with high frequency loss of heterozygosity in many tumours, CIDE-3 may play an important role in prevention of tumorigenesis. +ADw-/p+AD4- +ADw-p+AD4-Host Species: Rabbit +ADw-/p+AD4- +ADw-p+AD4-Specificity: Reacts with residues 10-25 +AFs-LLYPKSLSRHVSVRTS+AF0- of the 27 kDa human CIDE-3 protein. Cross reactivity to FSP27, +ADw-span class+AD0-GramE+AD4-which is the mouse homolog of CIDE-3: 93+ACU- sequence identity.+ADw-/span+AD4- +ADw-/p+AD4- +ADw-p+AD4-Applications: Western blot - Use at 1:500-1,000 +ADw-span class+AD0-GramE+AD4-dilution+ADw-/span+AD4-. However, the investigator should determine the optimal dilution for a specific application such as immunohistochemistry. +ADw-/p+AD4- +ADw-p+AD4-Format: Affinity purified IgG +ADw-/p+AD4- +ADw-p+AD4-Storage: Maintain at 8+ALA-C for 3 months or at -20+ALA-C for longer periods. +ADw-span class+AD0-GramE+AD4-Stable for 1 year.+ADw-/span+AD4- Avoid repeated freeze-thaw cycles. +ADw-/p+AD4- +ADw-p+AD4-Reference: Liang, L. et al. Biochem. J. 370 (Pt 1), 195-203 (2003). +ADw-/p+AD4- +ADw-p+AD4-For research use only+ADs- not for use in or on humans or animals-not for use in diagnostics +ADw-/p+AD4- +ADw-div class+AD0-MsoNormal align+AD0-center style+AD0-'text-align:center'+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- align+AD0-center+AD4- +ADw-/div+AD4- +ADw-p+AD4-RDI Division of Fitzgerald Industries Intl +ADw-/p+AD4- +ADw-p+AD4APA-st1:Street w:st+AD0AIg-on+ACIAPgA8-st1:address w:st+AD0AIg-on+ACIAPg-34 Junction Square+ADw-/st1:address+AD4APA-/st1:Street+AD4- Drive +ADw-/p+AD4- +ADw-p+AD4APA-st1:place w:st+AD0AIg-on+ACIAPgA8-st1:City w:st+AD0AIg-on+ACIAPg-Concord+ADw-/st1:City+AD4- +ADw-st1:State w:st+AD0AIg-on+ACIAPg-MA+ADw-/st1:State+AD4- +ADw-st1:PostalCode w:st+AD0AIg-on+ACIAPg-01742+ADw-/st1:PostalCode+AD4APA-/st1:place+AD4--3049 +ADw-/p+AD4- +ADw-p+AD4APA-st1:country-region w:st+AD0AIg-on+ACIAPgA8-st1:place w:st+AD0AIg-on+ACIAPg-USA+ADw-/st1:place+AD4APA-/st1:country-region+AD4- +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-phone+ADw-/span+AD4- (978) 371-6446 or (800) 370-2222 +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-fax+ADw-/span+AD4- +ACY-nbsp+ADs- +ACY-nbsp+ADs- (978) 371-2266 +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-mailto:antibodies+AEA-fitzgerald-fii.com+ACIAPg-EMAIL:antibodies+AEA-fitzgerald-fii.com+ADw-/a+AD4- +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/absort.htm+ACIAPg-Return +ADw-/a+AD4AJg-nbsp+ADs- (alphabetical antibody page) +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/terms.htm+ACIAPg-Ordering +ADw-/a+AD4-terms +ADw-/p+AD4- +ADw-/div+AD4- +ADw-/body+AD4- +ADw-/html+AD4-